Morgan Stanley Atara Biotherapeutics, Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Oct 17, 2024	BUY	$0.44 - $1.22 $592,296 - $1.64 Million	1,346,129 New	1,346,129 $928,000
Q1 2024 Aug 16, 2024	SELL	$0.44 - $1.22 $196,786 - $545,635	-447,242 Reduced 24.94%	1,346,129 $928,000
Q1 2024 May 15, 2024	SELL	$0.44 - $1.22 $196,786 - $545,635	-447,242 Reduced 24.94%	1,346,129 $928,000
Q4 2023 Aug 16, 2024	BUY	$0.23 - $1.74 $412,475 - $3.12 Million	1,793,371 New	1,793,371 $914,000
Q4 2023 Feb 13, 2024	SELL	$0.23 - $1.74 $96,902 - $733,086	-421,314 Reduced 19.02%	1,793,371 $914,000
Q3 2023 Nov 15, 2023	SELL	$1.41 - $2.31 $406,206 - $665,487	-288,090 Reduced 11.51%	2,214,685 $3.28 Million
Q2 2023 Aug 14, 2023	SELL	$1.5 - $3.04 $666,691 - $1.35 Million	-444,461 Reduced 15.08%	2,502,775 $4.03 Million
Q1 2023 May 15, 2023	BUY	$2.8 - $5.46 $720,977 - $1.41 Million	257,492 Added 9.57%	2,947,236 $8.55 Million
Q4 2022 Feb 14, 2023	SELL	$2.85 - $5.18 $738,640 - $1.34 Million	-259,172 Reduced 8.79%	2,689,744 $8.82 Million
Q3 2022 Nov 14, 2022	SELL	$2.85 - $8.73 $783,658 - $2.4 Million	-274,968 Reduced 8.53%	2,948,916 $11.1 Million
Q2 2022 Oct 27, 2022	BUY	$4.69 - $9.84 $864,685 - $1.81 Million	184,368 Added 6.07%	3,223,884 $25.1 Million
Q2 2022 Aug 15, 2022	BUY	$4.69 - $9.84 $864,685 - $1.81 Million	184,368 Added 6.07%	3,223,884 $25.1 Million
Q1 2022 Oct 27, 2022	SELL	$8.44 - $16.89 $1.56 Million - $3.11 Million	-184,368 Reduced 5.72%	3,039,516 $28.2 Million
Q1 2022 May 13, 2022	BUY	$8.44 - $16.89 $4.19 Million - $8.39 Million	496,468 Added 19.52%	3,039,516 $28.2 Million
Q4 2021 Feb 14, 2022	SELL	$14.7 - $19.89 $3.92 Million - $5.3 Million	-266,712 Reduced 9.49%	2,543,048 $40.1 Million
Q3 2021 Nov 15, 2021	BUY	$11.99 - $17.9 $33.7 Million - $50.3 Million	2,809,760 New	2,809,760 $50.3 Million

Others Institutions Holding ATRA

# of Institutions

Shares Held

2.89M

Call Options Held

Put Options Held

View Full List

About Atara Biotherapeutics, Inc.

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $1.08B
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

More about ATRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account